NCT02473757View on ClinicalTrials.gov

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Enrolling by invitationOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

September 24, 2015

Primary Completion Date

July 1, 2034

Study Completion Date

August 1, 2050

Conditions

Lyphoma, B-CellLeukemia, B-cellMultiple MyelomaHematologic Malignancies

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH